Orthopaedic Surgical Wound Infection Management Pathway
These materials are intended for general clinical education and guidance. They are not a substitute for a clinician’s knowledge, skill or judgment in treating patients.
Table of contents
1. Definitions and initial assessment
Surgical wound infection
Involves only skin and/or subcutaneous tissue of the incision and the patient has one or more of the following:
- Purulent drainage
- Localized pain/tenderness, localized swelling, erythema or warmth
- Onset is typically within 30 days of index surgery; if onset is greater than 30 days, consider ruling out deeper (joint) infection
NOT considered superficial SSI: stitch abscess alone confined to the points of suture penetration.
If suspicion of joint infection
- Serum CRP and ESR
- If febrile: 2 sets of blood cultures
- Arthrocentesis (2 separate samples):
- Cell count and differential, crystals and synovial CRP ⟶ send 2 mL or more in a sterile container
- Gram stain, culture and sensitivity ⟶ send 3.5 mL or more in a sterile container
Note: If no improvement after one week, consider non-infectious etiologies or deeper (joint) infection. If symptom onset is beyond 30 days after index surgery, wound infection is unlikely to represent a superficial SSI. Additional investigations may be warranted.
2. Imaging
Ultrasound, as per physician preference, to assess depth of soft tissue changes and rule out collection (for hips only).
Note: Plain film is helpful for assessing implant positioning, but not for detecting infection.
3. Microbiology
Usually NOT indicated. If an abscess is drained, send all available material to Microbiology in a sterile container.
Avoid superficial wound swabs.
4. Wound care
Consider use of a dressing with antiseptic or antimicrobial properties (e.g., AMD PHMB, Aquacel Ag+, Inadine).
Surgical wounds post-arthroplasty should never be packed unless specifically ordered by the primary surgeon.
5. Antibiotic therapy
1st line
Add MRSA coverage if known MRSA colonized.
| PO route | IV route |
|---|---|
| Cephalexin 500 mg PO qid If weight > 100 kg: 1 g PO qid | Cefazolin 1 g IV q8h If weight > 100 kg: 2 g IV q8h |
Allergy to beta-lactam
Add MRSA coverage if known MRSA colonized.
| PO route | IV route |
|---|---|
| Non-beta-lactam oral options are limited and associated with higher toxicity Consult Antimicrobial Stewardship if presence of a severe beta-lactam allergy | Vancomycin 15 mg/kg IV q12h |
Duration
7 days, with follow-up at the end of treatment when possible.